GlucoTrack
GCTK
8 hedge funds and large institutions have $41.5K invested in GlucoTrack in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.
4% more capital invested
Capital invested by funds: $40.1K → $41.5K (+$1.42K)
0.68% more ownership
Funds ownership: 0.02% → 0.7% (+0.68%)
20% less funds holding
Funds holding: 10 → 8 (-2)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AF
Alerus Financial
Grand Forks,
North Dakota
|
+$30.1K |
| 2 |
Morgan Stanley
New York
|
+$2.41K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$235 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$24.6K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.82K |
| 3 |
Barclays
London,
United Kingdom
|
-$4.51K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$128 |
| 5 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$6 |
GCTK Hedge Fund Activity: Q3 2025 in Review
8 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q3 2025, worth a combined $41.5K — up 3.5% from $40.1K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of GCTK and 1 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was Alerus Financial, opening a new position worth an estimated $30.1K. The largest seller was Bank of America, cutting an estimated $24.6K.
- 8 institutional investors held GlucoTrack (GCTK) as of Q3 2025, down from 10 in Q2 2025.
- Funds reported $41.5K of GlucoTrack stock for Q3 2025, up 3.5% quarter-over-quarter.
- 1 fund opened new GlucoTrack positions in Q3 2025 and 3 closed out, a net change of -2 holders.
- The largest GlucoTrack buyer in Q3 2025 was Alerus Financial, an estimated $30.1K added.
- The largest GlucoTrack seller in Q3 2025 was Bank of America, an estimated $24.6K sold.
Based on aggregated 13F filings for Q3 2025.